An update on the management of sporadic desmoid-type fibromatosis:a european consensus initiative between sarcoma patients euronet (spaen) and european organization for research and treatment of cancer (eortc)/soft tissue and bone sarcoma group (stbsg)

Autor: B. Kasper, C. Baumgarten, J. Garcia, S. Bonvalot, R. Haas, F. Haller, P. Hohenberger, N. Penel, C. Messiou, W.T. van der Graaf, A. Gronchi, S. Bauer, J.Y. Blay, F. van Coevorden, P. Dileo, H.R. Dürr, M. Fiore, V. Grünwald, R. Jones, I. Judson, C. Kettelhack, K. Kopeckova, A. Lazar, L.H. Lindner, J. Martin-Broto, P. Rutkowski, S. Stacchiotti, E. Stoeckle, C. Valverde, K. Verhoef, E. Wardelmann, M. Wartenberg

Publikováno v: Annals of Oncology
Annals of Oncology, Elsevier, 2017, Annals of oncology official journal of the European Society for Medical Oncology, 28, pp.2399-2408. ⟨10.1093/annonc/mdx323⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
Annals of Oncology, 28, 2399-2408
Annals of Oncology, 2017, Annals of oncology official journal of the European Society for Medical Oncology, 28, pp.2399-2408. ⟨10.1093/annonc/mdx323⟩
Annals of Oncology, 28, 10, pp. 2399-2408

Desmoid-type fibromatosis is a rare and locally aggressive monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Currently, there is no established or evidence-based treatment approach available f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe5adec7b93efaa9f3e0c38f39e552b
http://hdl.handle.net/20.500.12210/17223